Finding older adults who can safely benefit from lung cancer screening
Identifying older adults who benefit from lung cancer screening
This study is looking at how to help older adults aged 50-80 decide if lung cancer screening is right for them by figuring out who is healthy enough to benefit from it without facing unnecessary risks.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northern California Institute/res/edu NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10910151 on NIH RePORTER |
What this research studies
This research investigates how to identify older adults, specifically those aged 50-80, who are healthy enough to benefit from lung cancer screening while minimizing potential harms. The study aims to create individualized assessments of the net benefits of screening based on each person's health status. By analyzing national data, the research will explore the relationship between health conditions and the outcomes of lung cancer screening, focusing on preventing unnecessary complications. The goal is to improve decision-making regarding lung cancer screening for older adults.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 50-80 who are considering lung cancer screening and have no advanced comorbidities.
Not a fit: Patients with advanced comorbidities or those outside the age range of 50-80 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help ensure that older adults receive lung cancer screenings that are beneficial and safe for their specific health conditions.
How similar studies have performed: Other research has shown success in using individualized health assessments to improve screening outcomes, making this approach promising.
Where this research is happening
San Francisco, United States
- Northern California Institute/res/edu — San Francisco, United States (Active)
Researchers
- Principal investigator: Rustagi, Alison Silvis — Northern California Institute/res/edu
- Study coordinator: Rustagi, Alison Silvis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.